| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.42 | 0.08 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |